» Articles » PMID: 29604173

Cerebral Amyloid Angiopathy: Review of Clinico-radiological Features and Mimics

Overview
Specialties Oncology
Radiology
Date 2018 Apr 1
PMID 29604173
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral amyloid angiopathy (CAA) is an important cause of lobar intracerebral haemorrhage (ICH) in the elderly, but has other clinico-radiological manifestations. In the last two decades, certain magnetic resonance imaging (MRI) sequences, namely gradient-recalled echo imaging and the newer and more sensitive susceptibility-weighted imaging, have been utilised to detect susceptibility-sensitive lesions such as cerebral microbleeds and cortical superficial siderosis. These can be utilised sensitively and specifically by the Modified Boston Criteria to make a diagnosis of CAA without the need for 'gold-standard' histopathology from biopsy. However, recently, other promising MRI biomarkers of CAA have been described which may further increase precision of radiological diagnosis, namely chronic white matter ischaemia, cerebral microinfarcts and lobar lacunes, cortical atrophy, and increased dilated perivascular spaces in the centrum semiovale. However, the radiological manifestations of CAA, as well as their clinical correlates, may have other aetiologies and mimics. It is important for the radiologist to be aware of these clinico-radiological features and mimics to accurately diagnose CAA. This is increasingly important in a patient demographic that has a high prevalence for use of antiplatelet and antithrombotic medications for other comorbidities which inherently carries an increased risk of ICH in patients with CAA.

Citing Articles

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons.

Hu H, Wan S, Hu Y, Wang Q, Li H, Zhang N Ann Med. 2025; 57(1):2445194.

PMID: 39745195 PMC: 11703089. DOI: 10.1080/07853890.2024.2445194.


Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy.

Flemming K, Radford J, Reichard R, Klaas J, Braksick S, Cogswell P Acta Neurochir (Wien). 2024; 166(1):508.

PMID: 39715886 PMC: 11666656. DOI: 10.1007/s00701-024-06400-8.


When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies.

Merella P, Casu G, Chessa P, Atzori E, Bandino S, Deiana G J Clin Med. 2023; 12(24).

PMID: 38137773 PMC: 10743760. DOI: 10.3390/jcm12247704.


Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial.

Cloud G, Williamson J, Phuong Thao L, Tran C, Eaton C, Wolfe R JAMA Netw Open. 2023; 6(7):e2325803.

PMID: 37494038 PMC: 10372701. DOI: 10.1001/jamanetworkopen.2023.25803.


Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA.

Storti B, Gabriel M, Sennfalt S, Canavero I, Rifino N, Gatti L Front Neurosci. 2023; 17:1219025.

PMID: 37492402 PMC: 10363735. DOI: 10.3389/fnins.2023.1219025.